Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil/ Epirubicin/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers
- Author
- NAOI, Yasuto1 ; KISHI, Kazuki2 ; TANEI, Tomonori1 ; TSUNASHIMA, Ryo1 ; TOMINAGA, Naoomi1 ; BABA, Yosuke2 ; SEUNG JIN KIM1 ; TAGUCHI, Tetsuya1 ; TAMAKI, Yasuhiro1 ; NOGUCHI, Shinzaburo1
[1] Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
[2] Central Research Laboratories, Sysmex Corporation, Kobe, Japan - Source
Cancer. 2011, Vol 117, Num 16, pp 3682-3690, 9 p ; ref : 22 ref
- CODEN
- CANCAR
- ISSN
- 0008-543X
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Blackwell, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- DNA microarray breast cancer chemotherapy pathologic complete response prediction
- Keyword (fr)
- Anticancéreux Cancer du sein Cancérologie Chimiothérapie Cyclophosphamide Epirubicine Facteur prédictif Fluorouracil Paclitaxel Puce à DNA Séquentiel Thérapie génique Agent alkylant Anthracyclines Antimitotique Antimétabolite Cancer Dérivé de l'oxazaphosphinane Dérivé de la fluoropyrimidine Dérivé de la pyrimidine Dérivé du taxane Enzyme Inhibiteur enzyme Methyltransferases Moutarde à l'azote Pathologie de la glande mammaire Pathologie du sein Thymidylate synthase Traitement Transferases Tumeur maligne
- Keyword (en)
- Antineoplastic agent Breast cancer Cancerology Chemotherapy Cyclophosphamide Epirubicin Predictive factor Fluorouracil Paclitaxel DNA chip Sequential Gene therapy Alkylating agent Anthracyclins Antimitotic Antimetabolic Cancer Oxazaphosphinane derivatives Fluoropyrimidine derivatives Pyrimidine derivatives Taxane derivatives Enzyme Enzyme inhibitor Methyltransferases Nitrogen mustard Mammary gland diseases Breast disease Thymidylate synthase Treatment Transferases Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pecho Cancerología Quimioterapia Ciclofosfamida Epirubicina Factor predictivo Fluorouracilo Paclitaxel Pulga de DNA Secuencial Terapia génica Agente alquilante Antraciclinas Antimitótico Antimetabólito Cáncer Oxazafosfinano derivado Fluoropirimidina derivado Pirimidina derivado Taxane derivado Enzima Inhibidor enzima Methyltransferases Mostaza al nitrógeno Glándula mamaria patología Seno patología Thymidylate synthase Tratamiento Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24406653
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/cncr.25953 
https://dx.doi.org/10.1002/cncr.25953
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.25953\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"3682\";s:8:\"\u0000*\u0000epage\";s:4:\"3690\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"NAOI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Yasuto\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"KISHI, Kazuki\";i:1;s:15:\"TANEI, Tomonori\";i:2;s:15:\"TSUNASHIMA, Ryo\";i:3;s:16:\"TOMINAGA, Naoomi\";i:4;s:12:\"BABA, Yosuke\";i:5;s:13:\"SEUNG JIN KIM\";i:6;s:16:\"TAGUCHI, Tetsuya\";i:7;s:16:\"TAMAKI, Yasuhiro\";i:8;s:19:\"NOGUCHI, Shinzaburo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.25953\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"3682\";s:8:\"\u0000*\u0000epage\";s:4:\"3690\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"NAOI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Yasuto\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"KISHI, Kazuki\";i:1;s:15:\"TANEI, Tomonori\";i:2;s:15:\"TSUNASHIMA, Ryo\";i:3;s:16:\"TOMINAGA, Naoomi\";i:4;s:12:\"BABA, Yosuke\";i:5;s:13:\"SEUNG JIN KIM\";i:6;s:16:\"TAGUCHI, Tetsuya\";i:7;s:16:\"TAMAKI, Yasuhiro\";i:8;s:19:\"NOGUCHI, Shinzaburo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.25953\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.25953\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"3682\";s:8:\"\u0000*\u0000epage\";s:4:\"3690\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"NAOI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Yasuto\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"KISHI, Kazuki\";i:1;s:15:\"TANEI, Tomonori\";i:2;s:15:\"TSUNASHIMA, Ryo\";i:3;s:16:\"TOMINAGA, Naoomi\";i:4;s:12:\"BABA, Yosuke\";i:5;s:13:\"SEUNG JIN KIM\";i:6;s:16:\"TAGUCHI, Tetsuya\";i:7;s:16:\"TAMAKI, Yasuhiro\";i:8;s:19:\"NOGUCHI, Shinzaburo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.25953\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"3682\";s:8:\"\u0000*\u0000epage\";s:4:\"3690\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"NAOI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Yasuto\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"KISHI, Kazuki\";i:1;s:15:\"TANEI, Tomonori\";i:2;s:15:\"TSUNASHIMA, Ryo\";i:3;s:16:\"TOMINAGA, Naoomi\";i:4;s:12:\"BABA, Yosuke\";i:5;s:13:\"SEUNG JIN KIM\";i:6;s:16:\"TAGUCHI, Tetsuya\";i:7;s:16:\"TAMAKI, Yasuhiro\";i:8;s:19:\"NOGUCHI, Shinzaburo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.25953\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"117\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"3682\";s:8:\"\u0000*\u0000epage\";s:4:\"3690\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"NAOI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Yasuto\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:13:\"KISHI, Kazuki\";i:1;s:15:\"TANEI, Tomonori\";i:2;s:15:\"TSUNASHIMA, Ryo\";i:3;s:16:\"TOMINAGA, Naoomi\";i:4;s:12:\"BABA, Yosuke\";i:5;s:13:\"SEUNG JIN KIM\";i:6;s:16:\"TAGUCHI, Tetsuya\";i:7;s:16:\"TAMAKI, Yasuhiro\";i:8;s:19:\"NOGUCHI, Shinzaburo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:169:\"Prediction of Pathologic Complete Response to Sequential Paclitaxel and 5-Fluorouracil\/ Epirubicin\/Cyclophosphamide Therapy Using a 70-Gene Classifier for Breast Cancers\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
